$MASI
MASIMO CORP Stock $masi

$masi Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-Q Financial Statement

#000093755616000403 Filed on November 02, 2016

Income Statement

Concept	2016 Q1	2015 Q4
Revenue	$167.3M	$152.6M
YoY Change	3.38%
Cost Of Revenue	$65.50M	$50.34M
YoY Change	24.52%
Gross Profit	$101.7M	$102.2M
YoY Change	-6.83%
Gross Profit Margin	60.83%	67.0%
Selling, General & Admin	$70.70M	$59.61M
YoY Change	14.96%
% of Gross Profit	69.49%	58.31%
Research & Development	$13.80M	$14.49M
YoY Change	-8.0%
% of Gross Profit	13.56%	14.17%
Depreciation & Amortization	$4.100M	$3.900M
YoY Change	24.24%
% of Gross Profit	4.03%	3.81%
Operating Expenses	$84.50M	$74.09M
YoY Change	10.46%
Operating Profit	$36.89M	$28.14M
YoY Change	12.82%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$1.900M	-$1.050M
YoY Change	35.71%
Pretax Income	$35.00M	$27.09M
YoY Change	12.18%
Income Tax	$10.00M	$9.161M
% Of Pretax Income	28.57%	33.82%
Net Earnings	$24.10M	$19.33M
YoY Change	13.68%
Net Earnings / Revenue	14.41%	12.67%
Basic Earnings Per Share	$0.48	$0.38
Diluted Earnings Per Share	$0.46	$0.36
COMMON SHARES
Basic Shares Outstanding	49.49M shares	50.97M shares
Diluted Shares Outstanding		53.69M shares

Balance Sheet

Concept	2016 Q1	2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$132.3M	$103.6M
YoY Change	-1.64%
Cash & Equivalents	$132.3M	$103.6M
Short-Term Investments
Other Short-Term Assets	$21.42M	$37.21M
YoY Change	-0.22%
Inventory	$62.04M	$73.31M
Prepaid Expenses	$9.930M	$10.36M
Receivables	$80.96M	$75.47M
Other Receivables	$7.500M	$7.300M
Total Short-Term Assets	$299.1M	$297.5M
YoY Change	0.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$132.5M	$128.6M
YoY Change	29.93%
Goodwill	$20.39M	$20.45M
YoY Change	-2.79%
Intangibles	$27.56M	$27.88M
YoY Change	-0.77%
Long-Term Investments
YoY Change
Other Assets	$11.01M	$11.32M
YoY Change	47.13%
Total Long-Term Assets	$302.6M	$280.2M
YoY Change	12.94%
TOTAL ASSETS
Total Short-Term Assets	$299.1M	$297.5M
Total Long-Term Assets	$302.6M	$280.2M
Total Assets	$601.7M	$577.8M
YoY Change	6.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$25.87M	$28.74M
YoY Change	-32.01%
Accrued Expenses	$44.22M	$24.10M
YoY Change	80.2%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$100.0K	$100.0K
YoY Change	0.0%
Total Short-Term Liabilities	$132.6M	$111.8M
YoY Change	7.05%
LONG-TERM LIABILITIES
Long-Term Debt	$185.1M	$190.1M
YoY Change	47.96%
Other Long-Term Liabilities	$8.021M	$7.342M
YoY Change	3.19%
Total Long-Term Liabilities	$8.021M	$7.342M
YoY Change	3.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$132.6M	$111.8M
Total Long-Term Liabilities	$8.021M	$7.342M
Total Liabilities	$326.0M	$309.6M
YoY Change	26.73%
SHAREHOLDERS EQUITY
Retained Earnings	$288.6M	$264.5M
YoY Change	40.58%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$340.9M	$316.1M
YoY Change	83.36%
Treasury Stock Shares	14.26M shares	12.16M shares
Shareholders Equity	$275.4M	$269.2M
YoY Change
Total Liabilities & Shareholders Equity	$601.7M	$577.8M
YoY Change	6.5%

Cashflow Statement

Concept	2016 Q1	2015 Q4
OPERATING ACTIVITIES
Net Income	$24.10M	$19.33M
YoY Change	13.68%
Depreciation, Depletion And Amortization	$4.100M	$3.900M
YoY Change	24.24%
Cash From Operating Activities	$61.50M	$27.10M
YoY Change	113.54%
INVESTING ACTIVITIES
Capital Expenditures	-$10.60M	-$16.70M
YoY Change	12.77%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$10.60M	-$16.70M
YoY Change	12.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-21.30M	-26.20M
YoY Change	914.29%
NET CHANGE
Cash From Operating Activities	61.50M	27.10M
Cash From Investing Activities	-10.60M	-16.70M
Cash From Financing Activities	-21.30M	-26.20M
Net Change In Cash	29.60M	-15.80M
YoY Change	71.1%
FREE CASH FLOW
Cash From Operating Activities	$61.50M	$27.10M
Capital Expenditures	-$10.60M	-$16.70M
Free Cash Flow	$72.10M	$43.80M
YoY Change	88.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-10-01
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000937556
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49677592	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	MASIMO CORP
	dei	Trading Symbol TradingSymbol	MASI
CY2016Q1	masi	Accrued Arbitration Award Current AccruedArbitrationAwardCurrent	5391000	USD
CY2016Q4	masi	Accrued Arbitration Award Current AccruedArbitrationAwardCurrent	0	USD
CY2016Q1	masi	Accrued Donations Current AccruedDonationsCurrent	5612000	USD
CY2016Q4	masi	Accrued Donations Current AccruedDonationsCurrent	557000	USD
CY2016Q1	masi	Accrued Stock Repurchase Current AccruedStockRepurchaseCurrent	4815000	USD
CY2016Q4	masi	Accrued Stock Repurchase Current AccruedStockRepurchaseCurrent	0	USD
CY2016Q1	masi	Accruedcustomerrebatesfeesandreimbursement Accruedcustomerrebatesfeesandreimbursement	11857000	USD
CY2016Q4	masi	Accruedcustomerrebatesfeesandreimbursement Accruedcustomerrebatesfeesandreimbursement	25066000	USD
CY2016Q1	masi	Concentration Risk Longlived Asset Geographic Area Percentage ConcentrationRiskLonglivedAssetGeographicAreaPercentage	1.000
CY2016Q4	masi	Concentration Risk Longlived Asset Geographic Area Percentage ConcentrationRiskLonglivedAssetGeographicAreaPercentage	1.000
	masi	Deconsolidation Variable Interest Entity Reductionof Cash DeconsolidationVariableInterestEntityReductionofCash	0	USD
	masi	Deconsolidation Variable Interest Entity Reductionof Cash DeconsolidationVariableInterestEntityReductionofCash	-763000	USD
CY2007Q4	masi	Dividends Declared For Outstanding Common Stock DividendsDeclaredForOutstandingCommonStock	One preferred stock purchase right
CY2016Q4	masi	Estimateof Annual Preventable Hospital Deaths Preventedby2020 EstimateofAnnualPreventableHospitalDeathsPreventedby2020	200000	death
	masi	Long Term Sales Agreement Warranty Maximum LongTermSalesAgreementWarrantyMaximum	P6Y
	masi	Long Term Sales Agreement Warranty Minimum LongTermSalesAgreementWarrantyMinimum	P3Y
CY2007Q4	masi	Number Of Rights To Be Issued With Each Share Of Common Stock NumberOfRightsToBeIssuedWithEachShareOfCommonStock	1	shares
CY2007Q1	masi	Numberof Companieswith Rightsto Intellectual Property NumberofCompanieswithRightstoIntellectualProperty	2	company
CY2011Q3	masi	Numberof Former Sales Representatives NumberofFormerSalesRepresentatives	2	sales_representatives
CY2014Q1	masi	Numberof Participantsinthe Surfactant Positive Pressureand Oxygenation Randomized Trial NumberofParticipantsintheSurfactantPositivePressureandOxygenationRandomizedTrial	2	participant
	masi	Numberof Sourcesof Product Revenue NumberofSourcesofProductRevenue	4	segment
CY2015Q4	masi	Numberofinterpartesreviewpetitions Patent Trialand Appeal Boardofthe Us Patent Office NumberofinterpartesreviewpetitionsPatentTrialandAppealBoardoftheUSPatentOffice	3
CY2015Q4	masi	Percentage Of Revenue One Customer PercentageOfRevenueOneCustomer	0.145
	masi	Percentage Of Revenue One Customer PercentageOfRevenueOneCustomer	0.146
CY2016Q4	masi	Percentage Of Revenue One Customer PercentageOfRevenueOneCustomer	0.140
	masi	Percentage Of Revenue One Customer PercentageOfRevenueOneCustomer	0.150
CY2015Q4	masi	Percentage Of Revenue Two Customer PercentageOfRevenueTwoCustomer	0.116
	masi	Percentage Of Revenue Two Customer PercentageOfRevenueTwoCustomer	0.120
CY2016Q4	masi	Percentage Of Revenue Two Customer PercentageOfRevenueTwoCustomer	0.132
	masi	Percentage Of Revenue Two Customer PercentageOfRevenueTwoCustomer	0.124
CY2007Q4	masi	Preferred Stock Voting Rights Per Share PreferredStockVotingRightsPerShare	1.000
	masi	Proceedsfromstockoptionsexercisedunsettledatperiodend Proceedsfromstockoptionsexercisedunsettledatperiodend	0	USD
	masi	Proceedsfromstockoptionsexercisedunsettledatperiodend Proceedsfromstockoptionsexercisedunsettledatperiodend	476000	USD
CY2016Q1	masi	Property Plantand Equipment Occupied Square Feet PropertyPlantandEquipmentOccupiedSquareFeet	70700	sqft
	masi	Property Plantand Equipment Occupied Square Feet PropertyPlantandEquipmentOccupiedSquareFeet	16830	sqft
CY2015Q4	masi	Royalty Royalty	7972000	USD
	masi	Royalty Royalty	23266000	USD
CY2016Q4	masi	Royalty Royalty	7335000	USD
	masi	Royalty Royalty	23241000	USD
CY2016Q1	masi	Royalty Receivable RoyaltyReceivable	7200000	USD
CY2016Q4	masi	Royalty Receivable RoyaltyReceivable	7500000	USD
	masi	Royalty Revenue Numberof Days Royalty Revenueis Adjusted Subsequentto Quarter End RoyaltyRevenueNumberofDaysRoyaltyRevenueisAdjustedSubsequenttoQuarterEnd	P60D
CY2016Q4	masi	Severance Plan Participation Agreements SeverancePlanParticipationAgreements	7	Agreement
	masi	Supplemental Unemployment Benefits Severance Benefits Required Noticeof Resignation SupplementalUnemploymentBenefitsSeveranceBenefitsRequiredNoticeofResignation	P6M
CY2016Q1	masi	Unrecognized Tax Benefits Liabilities Noncurrent UnrecognizedTaxBenefitsLiabilitiesNoncurrent	7747000	USD
CY2016Q4	masi	Unrecognized Tax Benefits Liabilities Noncurrent UnrecognizedTaxBenefitsLiabilitiesNoncurrent	8374000	USD
CY2016Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	25865000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	32232000	USD
CY2016Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	80960000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	94374000	USD
CY2016Q1	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	0	USD
CY2016Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	29000	USD
CY2016Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	5263000	USD
CY2016Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	4661000	USD
CY2016Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	47073000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42867000	USD
CY2016Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	5785000	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	2186000	USD
CY2016Q1	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	200000	USD
CY2016Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	600000	USD
CY2016Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	65472000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	70222000	USD
CY2016Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-4739000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-5019000	USD
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y
CY2016Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	332417000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	368501000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8100000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9700000	USD
CY2016Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3300000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2800000	USD
CY2015Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	500000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	600000	shares
CY2016Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1400000	shares
CY2016Q1	us-gaap	Assets Assets	601735000	USD
CY2016Q4	us-gaap	Assets Assets	639453000	USD
CY2016Q1	us-gaap	Assets Current AssetsCurrent	299142000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	324622000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	7093000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1232000	USD
CY2016Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	71000	USD
CY2016Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	0	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	137000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	4000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	8000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	14000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	100000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	100000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	11000	USD
CY2016Q4	us-gaap	Cash Cash	125000000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	134453000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	103581000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132317000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	125988000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-30872000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-6329000	USD
CY2016Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	2100000	USD
CY2016Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	16100000	shares
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49881	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49677	shares
CY2016Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	50000	USD
CY2016Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	50000	USD
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000
CY2015Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19437000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	56953000	USD
CY2016Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	27303000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	85093000	USD
CY2015Q4	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000
CY2016Q4	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000
CY2016Q4	us-gaap	Contractual Obligation ContractualObligation	26286000	USD
CY2016Q4	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	5885000	USD
CY2016Q4	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	2611000	USD
CY2016Q4	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	4649000	USD
CY2016Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	5919000	USD
CY2016Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	5710000	USD
CY2016Q4	us-gaap	Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear	1512000	USD
CY2015Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	50343000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	154600000	USD
CY2016Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	57499000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	171954000	USD
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	273000	USD
CY2016Q2	us-gaap	Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount	0.3	USD
CY2016Q1	us-gaap	Deferred Costs DeferredCosts	71718000	USD
CY2016Q4	us-gaap	Deferred Costs DeferredCosts	83066000	USD
CY2016Q1	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	8319000	USD
CY2016Q4	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	9431000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5002000	USD
CY2016Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	21280000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	32137000	USD
CY2016Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	298000	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	375000	USD
CY2016Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	44320000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	39403000	USD
CY2016Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	194000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	194000	USD
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03
	us-gaap	Depreciation Depreciation	9500000	USD
	us-gaap	Depreciation Depreciation	8600000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11603000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12355000	USD
CY2016Q1	us-gaap	Due From Employees Current DueFromEmployeesCurrent	320000	USD
CY2016Q4	us-gaap	Due From Employees Current DueFromEmployeesCurrent	301000	USD
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.15
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5092000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	5003000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.73
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.36
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.10
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.62
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1835000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-382000	USD
CY2016Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	38415000	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	37099000	USD
CY2016Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	200000	USD
CY2016Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	28900000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	7700000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16336000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	21098000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	10852000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	4424000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	3123000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3479000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3842000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4096000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	43892000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50914000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27556000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	29816000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-423000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-478000	USD
CY2016Q1	us-gaap	Goodwill Goodwill	20394000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	20252000	USD
CY2015Q4	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2016Q4	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2015Q4	us-gaap	Gross Profit GrossProfit	102232000	USD
	us-gaap	Gross Profit GrossProfit	308238000	USD
CY2016Q4	us-gaap	Gross Profit GrossProfit	110122000	USD
	us-gaap	Gross Profit GrossProfit	339470000	USD
CY2015Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	27090000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	81336000	USD
CY2016Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	36058000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	110793000	USD
CY2015Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9161000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24889000	USD
CY2016Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8285000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25420000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	29854000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3755000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	25753000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4179000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9232000	USD
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	0	USD
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-1092000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5048000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13525000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-482000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	862000	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	1007000	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	11278000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3465000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	10857000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1436000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-810000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	12911000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	3661000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	2317000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-272000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1149000	USD
CY2015Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2712000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2293000	shares
CY2016Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4088000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3451000	shares
CY2016Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	27556000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	29816000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1548000	USD
	us-gaap	Interest Paid Net InterestPaidNet	2603000	USD
CY2016Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	31920000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	29404000	USD
CY2016Q1	us-gaap	Inventory Net InventoryNet	62038000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	67047000	USD
CY2016Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	25781000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	31469000	USD
CY2016Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4337000	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6174000	USD
CY2015Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1200000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4100000	USD
CY2016Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1500000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4500000	USD
CY2016Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	300000	USD
CY2016Q1	us-gaap	Liabilities Liabilities	326023000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	306266000	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	601735000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	621000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	472000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3486000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	639453000	USD
CY2016Q1	us-gaap	Liabilities Current LiabilitiesCurrent	132633000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3969000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	144335000	USD
CY2014Q4	us-gaap	Litigation Settlement Amount LitigationSettlementAmount	466800000	USD
CY2016Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	185071000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	152500000	USD
CY2016Q1	us-gaap	Minority Interest MinorityInterest	297000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-40764000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-75348000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-44006000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18429000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	55733000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	87830000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	19325000	USD
	us-gaap	Net Income Loss NetIncomeLoss	59199000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	27773000	USD
	us-gaap	Net Income Loss NetIncomeLoss	85373000	USD
CY2015Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1396000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2752000	USD
CY2016Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2016Q1	us-gaap	Noncurrent Assets NoncurrentAssets	210323000	USD
CY2016Q4	us-gaap	Noncurrent Assets NoncurrentAssets	229865000	USD
CY2015Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1050000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2022000	USD
CY2016Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-546000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	423000	USD
CY2015Q4	us-gaap	Operating Expenses OperatingExpenses	74092000	USD
	us-gaap	Operating Expenses OperatingExpenses	224880000	USD
CY2016Q4	us-gaap	Operating Expenses OperatingExpenses	73518000	USD
	us-gaap	Operating Expenses OperatingExpenses	229100000	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	28140000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	83358000	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	36604000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	110370000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	26149000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2607000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	4641000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	5696000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	5819000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	5885000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1501000	USD
CY2016Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4351000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7164000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	37213000	USD
CY2016Q1	us-gaap	Other Assets Current OtherAssetsCurrent	23827000	USD
CY2015Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	112000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	37213000	USD
CY2016Q1	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	3973000	USD
CY2016Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	8364000	USD
CY2016Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6139000	USD
	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	679000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9144000	USD
CY2016Q4	us-gaap	Other Commitment OtherCommitment	500000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	488000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	130157000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	68218000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2246000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-470000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-280000	USD
CY2015Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	18041000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	54201000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	27303000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	85093000	USD
CY2016Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	80000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	40520000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13697000	USD
CY2016Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2016Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2016Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9930000	USD
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	13023000	USD
CY2016Q1	us-gaap	Prepaid Taxes PrepaidTaxes	2404000	USD
CY2016Q4	us-gaap	Prepaid Taxes PrepaidTaxes	7996000	USD
	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	4000	USD
	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	107500000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	45000000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	24942000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	26063000	USD
CY2015Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1416000	USD
CY2015Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1215000	USD
CY2016Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1222000	USD
CY2016Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1292000	USD
CY2016Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1222000	USD
CY2016Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1292000	USD
	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	722000	USD
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-52000	USD
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	99000	USD
	us-gaap	Product Warranty Expense ProductWarrantyExpense	828000	USD
	us-gaap	Product Warranty Expense ProductWarrantyExpense	751000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.010
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1257000	shares
CY2015Q4	us-gaap	Profit Loss ProfitLoss	17929000	USD
	us-gaap	Profit Loss ProfitLoss	56447000	USD
CY2016Q4	us-gaap	Profit Loss ProfitLoss	27773000	USD
	us-gaap	Profit Loss ProfitLoss	85373000	USD
CY2016Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	197938000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	203372000	USD
CY2016Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	132466000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	133150000	USD
	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	3400000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	506000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	127000	USD
CY2016Q4	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	42800000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	42500000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	77500000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	81000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	72000	USD
CY2015Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14485000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	42808000	USD
CY2016Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15673000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44856000	USD
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	288560000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	373931000	USD
CY2015Q4	us-gaap	Revenues Revenues	152575000	USD
	us-gaap	Revenues Revenues	462838000	USD
CY2016Q4	us-gaap	Revenues Revenues	167621000	USD
	us-gaap	Revenues Revenues	511424000	USD
CY2015Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	144603000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	439572000	USD
CY2016Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	160286000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	488183000	USD
CY2015Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	59607000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	182072000	USD
CY2016Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	57845000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	184244000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8132000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9693000	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.356
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.374
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.319
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.357
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.323
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.320
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.019
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	4300000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5222000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	26.01
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.303
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.303
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.018
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.019
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.013
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	11800000	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.015
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.013
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.010
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	37100000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	141000	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	14.09
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.82
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.99
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	13.42
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	283800000	USD
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9202000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9026000	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.46
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28.05
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	174800000	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	20.43
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	29.32
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	39.34
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M9D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M9D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1292000	shares
CY2015Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	5000000.0	shares
CY2016Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	2900000	USD
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	275415000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	333187000	USD
CY2016Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	275712000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	333187000	USD
CY2016Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	2777000	USD
CY2016Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1941000	USD
CY2016Q4	us-gaap	Time Deposits At Carrying Value TimeDepositsAtCarryingValue	62500000	USD
CY2016Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	12759	shares
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	14255	shares
CY2016Q1	us-gaap	Treasury Stock Value TreasuryStockValue	340873000	USD
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	404276000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9400000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	8000000	USD
CY2015Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53686000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53946000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53565000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52837000	shares
CY2015Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50974000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51653000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49477000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49386000	shares
	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Periods</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company follows a conventional 52/53 week fiscal year. Under a conventional 52/53 week fiscal year, a 52 week fiscal year includes four quarters of 13 fiscal weeks while a 53 week fiscal year includes three 13 fiscal week quarters and one 14 fiscal week quarter. The Company’s last 53 week fiscal year was fiscal year 2014. Fiscal year </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> is a 52 week fiscal year. All references to years in these notes to condensed consolidated financial statements are fiscal years unless otherwise noted.</font></div></div>
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> Description of the Company</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Masimo Corporation (the Company) is a global medical technology company that develops, manufactures and markets a variety of noninvasive patient monitoring technologies. The Company’s mission is to improve patient outcomes and reduce cost of care by taking noninvasive monitoring to new sites and applications. The Company’s patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use, reusable or resposable sensors, software and/or cables. The Company primarily sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long term care facilities and consumers through its direct sales force, distributors and original equipment manufacturer (OEM) partners.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company invented Masimo Signal Extraction Technology</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt"> </sup></font><font style="font-family:inherit;font-size:10pt;">(SET</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">), which provides the capabilities of Measure-through Motion and Low Perfusion</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">™</sup></font><font style="font-family:inherit;font-size:10pt;"> pulse oximetry to address the primary limitations of conventional pulse oximetry. Over the years, the Company’s product offerings have expanded significantly to also include noninvasive optical blood constituent monitoring, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and optical gas monitoring. The Company also developed the Root</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> patient monitoring and connectivity platform and the Masimo Patient SafetyNet</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">™</sup></font><font style="font-family:inherit;font-size:10pt;"> remote patient surveillance monitoring system. These solutions and related products are based upon Masimo SET</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">, rainbow</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> and other proprietary algorithms. These software-based technologies are incorporated into a variety of product platforms depending on customers’ specifications. This technology is supported by a substantial intellectual property portfolio that the Company has built through internal development and, to a lesser extent, acquisitions and license agreements.</font></div></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-align:left;padding-left:18px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications</font><font style="font-family:inherit;font-size:12pt;"> </font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain amounts in the condensed consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. </font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company prepares its financial statements in conformity with GAAP, which requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates include the determination of accounts receivable allowances, inventory reserves, warranty reserves, rebate accruals, valuation of the Company’s stock options, goodwill valuation, deferred taxes and any associated valuation allowances, distributor channel inventory, royalty revenues, deferred revenue, uncertain income tax positions, litigation costs and related accruals. Actual results could differ from such estimates.</font></div><div style="line-height:120%;padding-top:17px;text-align:left;padding-left:18px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"></font></div></div>

Files In Submission

Name	View Source	Status
0000937556-16-000403-index-headers.html	Edgar Link	pending
0000937556-16-000403-index.html	Edgar Link	pending
0000937556-16-000403.txt	Edgar Link	pending
0000937556-16-000403-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
masi-20161001.xml	Edgar Link	completed
masi-20161001.xsd	Edgar Link	pending
masi-20161001x10q.htm	Edgar Link	pending
masi-20161001x10qex121.htm	Edgar Link	pending
masi-20161001x10qex311.htm	Edgar Link	pending
masi-20161001x10qex312.htm	Edgar Link	pending
masi-20161001x10qex321.htm	Edgar Link	pending
masi-20161001_cal.xml	Edgar Link	unprocessable
masi-20161001_def.xml	Edgar Link	unprocessable
masi-20161001_lab.xml	Edgar Link	unprocessable
masi-20161001_pre.xml	Edgar Link	unprocessable
masimologoq32016-01.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MASI
MASIMO CORP Stock $masi

2016 Q1 Form 10-Q Financial Statement

#000093755616000403 Filed on November 02, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MASI MASIMO CORP Stock $masi

2016 Q1 Form 10-Q Financial Statement

#000093755616000403 Filed on November 02, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MASI
MASIMO CORP Stock $masi